Clinical trials are imperative for testing novel cancer therapies, advancing the science of
cancer care, and determining the best treatment strategies to enhance outcomes for patients …

Background Underrepresentation of racial and ethnic minorities in clinical trials remains a
reality while they have disproportionately higher rates of health disparities. Objective The …

A concerted commitment across research stakeholders is necessary to increase equity,
diversity, and inclusion (EDI) and address barriers to cancer clinical trial recruitment and …

Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled | PLOS Medicine
Skip to main content Advertisement PLOS Medicine Browse Current Issue Journal Archive …

Background In recent years, extensive attention has been paid to the possibility that bias
among health care professionals contributes to health disparities. In its 2003 report, the …

Women and people from most racial and ethnic groups in the United States have historically
been under‐represented in clinical trials of investigational medical products. Inadequate …

Background The process of informed consent for enrolment to a clinical research study can
be complex for both participants and research staff. Challenges include respecting the …

Background Although disproportionately affected by cardiovascular disease, Black adults
remain underrepresented in clinical trials. The National Institutes of Health recommends that …

Background Racial and ethnic minorities (REMs) continue to be underrepresented in clinical
trials despite the 1993 National Institutes of Health's Revitalization Act mandating the …

Chronic obstructive pulmonary disease (COPD) was the fourth leading cause of death
worldwide in 2015. Current treatments for patients ease discomfort and help decrease …